Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Günther G[au]:

In reply. Merker M et al. Int J Tuberc Lung Dis. (2016)

Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring. Verbeeck RK et al. Eur J Clin Pharmacol. (2016)

Scanning fluorescence correlation spectroscopy comes full circle. Gunther G et al. Methods. (2018)

Search results

Items: 1 to 50 of 209

1.

Crystal structures and protein engineering of three different penicillin G acylases from Gram-positive bacteria with different thermostability.

Mayer J, Pippel J, Günther G, Müller C, Lauermann A, Knuuti T, Blankenfeldt W, Jahn D, Biedendieck R.

Appl Microbiol Biotechnol. 2019 Jun 21. doi: 10.1007/s00253-019-09977-8. [Epub ahead of print]

PMID:
31227867
2.

Development and Characterization of Florfenicol-Loaded BSA Nanoparticles as Controlled Release Carrier.

Arriagada F, Günther G, Zabala I, Rubio-Retama J, Morales J.

AAPS PharmSciTech. 2019 May 28;20(5):202. doi: 10.1208/s12249-019-1419-7.

PMID:
31140015
3.

Mechanism of Visible-Light Photooxidative Demethylation of Toluidine Blue O.

Robinson-Duggon J, Mariño-Ocampo N, Barrias P, Zúñiga-Núñez D, Günther G, Edwards AM, Greer A, Fuentealba D.

J Phys Chem A. 2019 Jun 13;123(23):4863-4872. doi: 10.1021/acs.jpca.9b03588. Epub 2019 Jun 4.

PMID:
31117602
4.

Effectiveness of community-based DOTS strategy on tuberculosis treatment success rates in Namibia.

Kibuule D, Rennie TW, Ruswa N, Mavhunga F, Thomas A, Amutenya R, Law MR, Günther G, Ette E, Godman B, Verbeeck RK.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):441-449. doi: 10.5588/ijtld.17.0785.

PMID:
31064623
5.

Pipe-3D: A Pipeline Based on Immunofluorescence, 3D Confocal Imaging, Reconstructions, and Morphometry for Biliary Network Analysis in Cholestasis.

Damle-Vartak A, Begher-Tibbe B, Gunther G, Geisler F, Vartak N, Hengstler JG.

Methods Mol Biol. 2019;1981:25-53. doi: 10.1007/978-1-4939-9420-5_3.

PMID:
31016646
6.

Spectral and Kinetic Study of 3-Styrylquinoxalin-2(1 H)-ones Photoreduced by N-Phenylglycine and Amines.

Díaz-Hernández D, Cañete Á, Pavez L, Pérez-Sanhueza A, Günther G, Szreder T, De la Fuente JR.

J Phys Chem B. 2019 May 2;123(17):3688-3698. doi: 10.1021/acs.jpcb.9b01950. Epub 2019 Apr 22.

PMID:
30964986
7.

Phytoestrogen coumestrol: Antioxidant capacity and its loading in albumin nanoparticles.

Montero G, Arriagada F, Günther G, Bollo S, Mura F, Berríos E, Morales J.

Int J Pharm. 2019 May 1;562:86-95. doi: 10.1016/j.ijpharm.2019.03.029. Epub 2019 Mar 16.

PMID:
30885651
8.

Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal Cancer.

Weisner J, Landel I, Reintjes C, Uhlenbrock N, Trajkovic-Arsic M, Dienstbier N, Hardick J, Ladigan S, Lindemann M, Smith S, Quambusch L, Scheinpflug R, Depta L, Gontla R, Unger A, Müller H, Baumann M, Schultz-Fademrecht C, Günther G, Maghnouj A, Müller MP, Pohl M, Teschendorf C, Wolters H, Viebahn R, Tannapfel A, Uhl W, Hengstler JG, Hahn SA, Siveke JT, Rauh D.

Cancer Res. 2019 May 1;79(9):2367-2378. doi: 10.1158/0008-5472.CAN-18-2861. Epub 2019 Mar 11.

PMID:
30858154
9.

Antioxidant Nanomaterial Based on Core⁻Shell Silica Nanospheres with Surface-Bound Caffeic Acid: A Promising Vehicle for Oxidation-Sensitive Drugs.

Arriagada F, Günther G, Nos J, Nonell S, Olea-Azar C, Morales J.

Nanomaterials (Basel). 2019 Feb 6;9(2). pii: E214. doi: 10.3390/nano9020214.

10.

Pyrrolizidine alkaloid-induced alterations of prostanoid synthesis in human endothelial cells.

Ebmeyer J, Behrend J, Lorenz M, Günther G, Reif R, Hengstler JG, Braeuning A, Lampen A, Hessel-Pras S.

Chem Biol Interact. 2019 Jan 25;298:104-111. doi: 10.1016/j.cbi.2018.11.007. Epub 2018 Nov 19.

PMID:
30465738
12.

Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.

Salzer HJF, Schäfer G, Hoenigl M, Günther G, Hoffmann C, Kalsdorf B, Alanio A, Lange C.

Respiration. 2018;96(1):52-65. doi: 10.1159/000487713. Epub 2018 Apr 10. Review.

13.

Time to revise WHO-recommended definitions of MDR-TB treatment outcomes.

Lange C, van Leth F, Mitnick CD, Dheda K, Günther G.

Lancet Respir Med. 2018 Apr;6(4):246-248. doi: 10.1016/S2213-2600(18)30104-8. No abstract available.

PMID:
29595505
14.

Treatment responses in multidrug-resistant tuberculosis in Germany.

Heyckendorf J, van Leth F, Avsar K, Glattki G, Günther G, Kalsdorf B, Müller M, Olaru ID, Rolling T, Salzer HJF, Schuhmann M, Terhalle E, Lange C.

Int J Tuberc Lung Dis. 2018 Apr 1;22(4):399-406. doi: 10.5588/ijtld.17.0741.

PMID:
29562987
15.

Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.

Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Magis-Escurra C, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C; for TBNET.

Am J Respir Crit Care Med. 2018 Aug 1;198(3):379-386. doi: 10.1164/rccm.201710-2141OC.

PMID:
29509468
16.

Relapse-free cure from multidrug-resistant tuberculosis in Germany.

Heyckendorf J, van Leth F, Kalsdorf B, Olaru ID, Günther G, Salzer HJF, Terhalle E, Rolling T, Glattki G, Müller M, Schuhmann M, Avsar K, Lange C.

Eur Respir J. 2018 Feb 21;51(2). pii: 1702122. doi: 10.1183/13993003.02122-2017. Print 2018 Feb. No abstract available.

PMID:
29467205
17.

Scanning fluorescence correlation spectroscopy comes full circle.

Gunther G, Jameson DM, Aguilar J, Sánchez SA.

Methods. 2018 May 1;140-141:52-61. doi: 10.1016/j.ymeth.2018.01.023. Epub 2018 Feb 7. Review.

PMID:
29408224
18.

Study of rabbit erythrocytes membrane solubilization by sucrose monomyristate using laurdan and phasor analysis.

Günther G, Herlax V, Lillo MP, Sandoval-Altamirano C, Belmar LN, Sánchez SA.

Colloids Surf B Biointerfaces. 2018 Jan 1;161:375-385. doi: 10.1016/j.colsurfb.2017.10.068. Epub 2017 Nov 1.

PMID:
29102849
19.

Surveillance study on the tolerability and safety of Flebogamma® DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients.

Alsina L, Mohr A, Montañés M, Oliver X, Martín E, Pons J, Drewe E, Papke J, Günther G, Chee R, Gompels M; investigators of the Flebogamma DIF PASS Study Group.

Pharmacol Res Perspect. 2017 Oct;5(5). doi: 10.1002/prp2.345.

20.

Structure-Guided Development of Covalent and Mutant-Selective Pyrazolopyrimidines to Target T790M Drug Resistance in Epidermal Growth Factor Receptor.

Engel J, Smith S, Lategahn J, Tumbrink HL, Goebel L, Becker C, Hennes E, Keul M, Unger A, Müller H, Baumann M, Schultz-Fademrecht C, Günther G, Hengstler JG, Rauh D.

J Med Chem. 2017 Sep 28;60(18):7725-7744. doi: 10.1021/acs.jmedchem.7b00515. Epub 2017 Sep 18.

PMID:
28853575
21.

An HPLC Method for the Determination of Isoflavones and the Evaluation of Their Antioxidant Capacity in Both Homogeneous and Microheterogeneous Systems.

Montero G, Günther G, Valdés K, Arriagada F, Morales J.

J AOAC Int. 2018 Jan 1;101(1):235-241. doi: 10.5740/jaoacint.17-0104. Epub 2017 Aug 2.

PMID:
28766479
22.

Understanding the interaction of concanavalin a with mannosyl glycoliposomes: A surface plasmon resonance and fluorescence study.

Sandoval-Altamirano C, Sanchez SA, Ferreyra NF, Gunther G.

Colloids Surf B Biointerfaces. 2017 Oct 1;158:539-546. doi: 10.1016/j.colsurfb.2017.07.026. Epub 2017 Jul 18.

PMID:
28743089
23.

Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.

van Leth F, Günther G, Hoffmann H, Lange C; European MDR-TB Database Collaboration.

Am J Respir Crit Care Med. 2017 Dec 1;196(11):1489-1490. doi: 10.1164/rccm.201705-0995LE. No abstract available.

PMID:
28715229
24.

Early extubation in pediatric heart surgery across a spectrum of case complexity: Impact on hospital length of stay and chest tube days.

Beamer S, Ferns S, Edwards L, Gunther G, Nelson J.

Prog Pediatr Cardiol. 2017 Jun;45:63-68. doi: 10.1016/j.ppedcard.2016.12.001. Epub 2016 Dec 6.

25.

Treatment outcomes of MDR-TB and HIV co-infection in Europe.

Magis-Escurra C, Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBnet.

Eur Respir J. 2017 Jun 8;49(6). pii: 1602363. doi: 10.1183/13993003.02363-2016. Print 2017 Jun. No abstract available.

26.

Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.

Dedicoat MJ, Günther G, Crudu V, Duarte R, Gualano G, Magis-Escurra C, Rumetshofer R, Skrahina A, Spinu V, Tiberi S, Viiklepp P, van Leth F, Lange C; for TBNET ‡.

Am J Respir Crit Care Med. 2017 Nov 1;196(9):1222-1224. doi: 10.1164/rccm.201612-2585LE. No abstract available.

PMID:
28323453
27.

Reduced proliferation and colony formation of head and neck squamous cell carcinoma (HNSCC) after dual targeting of EGFR and hedgehog pathways.

Liebig H, Günther G, Kolb M, Mozet C, Boehm A, Dietz A, Wichmann G.

Cancer Chemother Pharmacol. 2017 Feb;79(2):411-420. doi: 10.1007/s00280-017-3239-3. Epub 2017 Jan 21.

PMID:
28110457
28.

The binuclear dual emitter [Br(CO)3Re(PN)(NP)Re(CO)3Br] (PN): 3-chloro-6-(4-diphenylphosphinyl)butoxypyridazine, a new bridging P,N-bidentate ligand resulting from the ring opening of tetrahydrofuran.

Saldías M, Manzur J, Palacios RE, Gómez ML, Fuente J, Günther G, Pizarro N, Vega A.

Dalton Trans. 2017 Jan 31;46(5):1567-1576. doi: 10.1039/c6dt04158b.

PMID:
28091640
29.

More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.

Lange C, Günther G, van Leth F; TBNET.

N Engl J Med. 2016 Dec 29;375(26):2611. doi: 10.1056/NEJMc1613123. No abstract available.

PMID:
28029919
30.

In vivo imaging of systemic transport and elimination of xenobiotics and endogenous molecules in mice.

Reif R, Ghallab A, Beattie L, Günther G, Kuepfer L, Kaye PM, Hengstler JG.

Arch Toxicol. 2017 Mar;91(3):1335-1352. doi: 10.1007/s00204-016-1906-5. Epub 2016 Dec 20.

31.

Morin Flavonoid Adsorbed on Mesoporous Silica, a Novel Antioxidant Nanomaterial.

Arriagada F, Correa O, Günther G, Nonell S, Mura F, Olea-Azar C, Morales J.

PLoS One. 2016 Nov 3;11(11):e0164507. doi: 10.1371/journal.pone.0164507. eCollection 2016.

32.

Potential use of nanocarriers with pentacyclic triterpenes in cancer treatments.

Valdés K, Morales J, Rodríguez L, Günther G.

Nanomedicine (Lond). 2016 Dec;11(23):3139-3156. Epub 2016 Nov 4. Review.

PMID:
27809705
33.

Treatment Outcomes in Multidrug-Resistant Tuberculosis.

Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBNET.

N Engl J Med. 2016 Sep 15;375(11):1103-5. doi: 10.1056/NEJMc1603274. No abstract available.

34.

Personalized Medicine for Chronic Respiratory Infectious Diseases: Tuberculosis, Nontuberculous Mycobacterial Pulmonary Diseases, and Chronic Pulmonary Aspergillosis.

Salzer HJ, Wassilew N, Köhler N, Olaru ID, Günther G, Herzmann C, Kalsdorf B, Sanchez-Carballo P, Terhalle E, Rolling T, Lange C, Heyckendorf J.

Respiration. 2016;92(4):199-214. Epub 2016 Sep 6. Review.

35.

Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.

Verbeeck RK, Günther G, Kibuule D, Hunter C, Rennie TW.

Eur J Clin Pharmacol. 2016 Aug;72(8):905-16. doi: 10.1007/s00228-016-2083-4. Epub 2016 Jun 15. Review.

PMID:
27305904
37.

In reply.

Merker M, Crudu V, Noroc E, Romancenco E, Chesov D, Günther G, Niemann S, Lange C.

Int J Tuberc Lung Dis. 2016 Mar;20(3):424. doi: 10.5588/ijtld.15.1024-2. No abstract available.

PMID:
27046728
38.

Activated ErbB3 Translocates to the Nucleus via Clathrin-independent Endocytosis, Which Is Associated with Proliferating Cells.

Reif R, Adawy A, Vartak N, Schröder J, Günther G, Ghallab A, Schmidt M, Schormann W, Hengstler JG.

J Biol Chem. 2016 Feb 19;291(8):3837-47. doi: 10.1074/jbc.M115.686782. Epub 2015 Dec 30.

39.

Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.

Günther G, van Leth F, Altet N, Dedicoat M, Duarte R, Gualano G, Kunst H, Muylle I, Spinu V, Tiberi S, Viiklepp P, Lange C; TBNET.

Int J Tuberc Lung Dis. 2015 Dec;19(12):1524-7. doi: 10.5588/ijtld.15.0274.

PMID:
26614196
40.

Nosocomial transmission of multidrug-resistant tuberculosis.

Crudu V, Merker M, Lange C, Noroc E, Romancenco E, Chesov D, Günther G, Niemann S.

Int J Tuberc Lung Dis. 2015 Dec;19(12):1520-3. doi: 10.5588/ijtld.15.0327.

PMID:
26614195
41.

Bile canalicular dynamics in hepatocyte sandwich cultures.

Reif R, Karlsson J, Günther G, Beattie L, Wrangborg D, Hammad S, Begher-Tibbe B, Vartak A, Melega S, Kaye PM, Hengstler JG, Jirstrand M.

Arch Toxicol. 2015 Oct;89(10):1861-70. doi: 10.1007/s00204-015-1575-9. Epub 2015 Aug 18.

PMID:
26280096
42.

Flavonoids in Microheterogeneous Media, Relationship between Their Relative Location and Their Reactivity towards Singlet Oxygen.

Günther G, Berríos E, Pizarro N, Valdés K, Montero G, Arriagada F, Morales J.

PLoS One. 2015 Jun 22;10(6):e0129749. doi: 10.1371/journal.pone.0129749. eCollection 2015.

43.

Paenibacillus larvae-Directed Bacteriophage HB10c2 and Its Application in American Foulbrood-Affected Honey Bee Larvae.

Beims H, Wittmann J, Bunk B, Spröer C, Rohde C, Günther G, Rohde M, von der Ohe W, Steinert M.

Appl Environ Microbiol. 2015 Aug 15;81(16):5411-9. doi: 10.1128/AEM.00804-15. Epub 2015 Jun 5.

44.

Structuration in the interface of direct and reversed micelles of sucrose esters, studied by fluorescent techniques.

Sandoval C, Ortega A, Sanchez SA, Morales J, Gunther G.

PLoS One. 2015 Apr 23;10(4):e0123669. doi: 10.1371/journal.pone.0123669. eCollection 2015.

45.

Correction: Sucrose monoester micelles size determined by fluorescence correlation spectroscopy (FCS).

Sanchez SA, Gratton E, Zanocco AL, Lemp E, Gunther G.

PLoS One. 2015 Apr 17;10(4):e0125123. doi: 10.1371/journal.pone.0125123. eCollection 2015. No abstract available.

46.

Dual Emission of a Novel (P,N) Re(I) Complex: A Computational and Experimental Study on [P,N-{(C6H5)2(C5H4N)P}Re(CO)3Br].

Pizarro N, Duque M, Chamorro E, Nonell S, Manzur J, de la Fuente JR, Günther G, Cepeda-Plaza M, Vega A.

J Phys Chem A. 2015 Apr 30;119(17):3929-35. doi: 10.1021/jp512614w. Epub 2015 Apr 15.

PMID:
25853537
47.

Multidrug-resistant tuberculosis in Europe, 2010-2011.

Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Pontali E, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C; TBNET.

Emerg Infect Dis. 2015 Mar;21(3):409-16. doi: 10.3201/eid2103.141343.

48.

'Tree-in-bud': thinking beyond infectious causes.

Terhalle E, Günther G.

Respiration. 2015;89(2):162-5. doi: 10.1159/000370050. Epub 2015 Jan 21.

49.

Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey.

Günther G, Gomez GB, Lange C, Rupert S, van Leth F; TBNET.

Eur Respir J. 2015 Apr;45(4):1081-8. doi: 10.1183/09031936.00124614. Epub 2014 Nov 13.

50.

Polyketide synthase (PKS) reduces fusion of Legionella pneumophila-containing vacuoles with lysosomes and contributes to bacterial competitiveness during infection.

Shevchuk O, Pägelow D, Rasch J, Döhrmann S, Günther G, Hoppe J, Ünal CM, Bronietzki M, Gutierrez MG, Steinert M.

Int J Med Microbiol. 2014 Nov;304(8):1169-81. doi: 10.1016/j.ijmm.2014.08.010. Epub 2014 Aug 23.

PMID:
25218702

Supplemental Content

Loading ...
Support Center